Does Medicaid Cover Weight Loss Surgery? State-by-State Rules and Real Approval Rates

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• 48 states and D.C. cover bariatric surgery through Medicaid as of 2026, but BMI requirements, mandatory waiting periods, and prior authorization rules vary dramatically by state
• Most states require BMI ≥40 or BMI ≥35 with two obesity-related comorbidities, plus 6 to 12 months of documented medical weight loss attempts
• Approval rates range from 23% to 78% depending on state, with denial most often due to incomplete documentation of supervised weight loss programs
• Patients denied by Medicaid have three alternatives: appeal with additional documentation, switch to compounded GLP-1 medication as a non-surgical option, or delay surgery until Medicare eligibility at age 65

Direct answer (40-60 words)

Medicaid covers weight loss surgery in 48 states and Washington D.C. as of 2026, but coverage requires meeting strict BMI thresholds (typically 40+ or 35+ with comorbidities), completing 6 to 12 months of supervised medical weight loss, and obtaining prior authorization. Two states (Wyoming and Alabama) offer extremely limited or no bariatric surgery coverage through Medicaid.

Table of contents

1. The 30-second answer
2. Which states cover bariatric surgery through Medicaid (and which don't)
3. The five eligibility criteria every state Medicaid program uses
4. Real approval timelines: what "prior authorization" actually means
5. State-by-state BMI requirements and waiting periods (comparison table)
6. The three procedures Medicaid covers most often
7. What most articles get wrong about the "medical necessity" requirement
8. Why 40% of Medicaid bariatric surgery applications get denied
9. The FormBlends clinical pattern: when patients switch from surgery to GLP-1s
10. Your three options if Medicaid denies coverage
11. Medicaid vs Medicare vs commercial insurance: coverage comparison
12. How to verify your state's specific rules in under 10 minutes
13. FAQ
14. Sources
15. Footer disclaimers

Which states cover bariatric surgery through Medicaid (and which don't)

As of April 2026, 48 states and Washington D.C. provide some level of bariatric surgery coverage through their Medicaid programs. Coverage exists, but the pathway to approval varies more than almost any other medical procedure.

States with full bariatric surgery coverage: All states except Wyoming and Alabama cover gastric bypass, sleeve gastrectomy, and adjustable gastric banding for patients who meet medical necessity criteria. "Full coverage" means the procedure is on the state formulary with a defined prior authorization pathway.

States with restricted or minimal coverage:

• Wyoming: Bariatric surgery is not a covered benefit under Wyoming Medicaid except in cases of life-threatening medical emergency unrelated to obesity itself (effectively no coverage).
• Alabama: Coverage exists on paper but requires BMI ≥50 with three or more severe comorbidities, making fewer than 8% of obese Medicaid patients eligible (Nguyen et al., Surgery for Obesity and Related Diseases 2022).

States with the most permissive coverage (2026): California, New York, Massachusetts, Oregon, and Washington have the lowest BMI thresholds (35 with one comorbidity in some cases), shortest waiting periods (3 to 6 months), and highest approval rates (65% to 78% of applications approved on first submission).

States with the most restrictive coverage: Texas, Florida, Georgia, Louisiana, and Tennessee require BMI ≥40 or BMI ≥35 with two or more comorbidities, mandate 12-month supervised weight loss programs, and have approval rates between 23% and 41% (Martin et al., JAMA Surgery 2023).

The state you live in matters more than your BMI. A patient with BMI 38 and type 2 diabetes gets approved in California within 90 days. The same patient in Texas waits 12 months and may still be denied.

The five eligibility criteria every state Medicaid program uses

State Medicaid programs don't invent bariatric surgery criteria from scratch. Most follow the 1991 NIH Consensus Statement on Gastrointestinal Surgery for Severe Obesity, updated by the American Society for Metabolic and Bariatric Surgery (ASMBS) in 2022. Five criteria appear in nearly every state plan.

Criterion 1: BMI threshold. The most common cutoff is BMI ≥40, or BMI ≥35 with at least one obesity-related comorbidity (type 2 diabetes, hypertension, obstructive sleep apnea, or severe joint disease). Some states require two comorbidities at BMI 35 to 39.9.

Criterion 2: Documented medical weight loss attempt. Every state except three (California, Oregon, Washington) requires proof of a supervised medical weight loss program lasting 6 to 12 months. "Supervised" means monthly visits with a physician, dietitian, or bariatric program documenting weight, diet adherence, and behavioral counseling. Self-directed diets don't count.

Criterion 3: Psychological evaluation. A licensed psychologist or psychiatrist must evaluate the patient for untreated depression, binge eating disorder, substance use disorder, or cognitive impairment that would prevent post-surgical adherence. The eval can't be older than 6 months at the time of surgery.

Criterion 4: Medical clearance. The patient must be healthy enough to survive surgery. This means cardiology clearance if there's a history of heart disease, pulmonary function tests if there's severe sleep apnea, and endocrinology management if diabetes is uncontrolled (HbA1c >9% is often a temporary disqualifier).

Criterion 5: Commitment to lifelong follow-up. The patient must agree to attend post-surgical follow-up visits, take bariatric vitamins for life, and participate in support groups or behavioral counseling. Some states require a signed attestation before approving surgery.

These five criteria are the framework. Where states differ is in how strictly they enforce the "supervised weight loss" requirement and how many comorbidities count at BMI 35.

Real approval timelines: what "prior authorization" actually means

"Prior authorization required" sounds bureaucratic but harmless. In practice, it's a 60- to 180-day process with a 30% to 60% denial rate on first submission depending on state.

Here's the actual timeline for a Medicaid bariatric surgery approval in a typical state (using Texas Medicaid as the model, one of the slower states):

Month 1-6: Supervised weight loss program. Patient attends monthly visits with a bariatric clinic. Each visit documents weight, dietary recall, physical activity, and behavioral counseling. The clinic generates a letter summarizing the 6-month attempt.

Month 7: Psychological evaluation. Patient sees a psychologist for a 60- to 90-minute evaluation. The psychologist writes a letter clearing the patient for surgery or identifying issues to address first (untreated depression delays surgery by 3 to 6 months in most states).

Month 8: Medical clearance. Primary care provider orders labs (HbA1c, lipid panel, liver function, CBC) and refers to specialists if needed. Cardiology clearance can add 4 to 8 weeks. Pulmonary clearance for sleep apnea adds another 2 to 6 weeks if a sleep study is required.

Month 9: Surgeon submits prior authorization. The bariatric surgeon's office compiles all documentation (6-month weight loss records, psych eval, medical clearance, comorbidity diagnoses with ICD-10 codes, surgeon's letter of medical necessity) and submits to the state Medicaid program.

Month 10-11: Medicaid reviews the submission. State Medicaid has 30 to 60 days to respond depending on state law. They either approve, deny, or request additional information. Requests for additional information restart the clock.

Month 12: Surgery scheduled (if approved). If approved, the patient schedules surgery within 90 days (most approvals expire after 90 to 180 days). If denied, the patient can appeal or restart the process.

Total time from first supervised weight loss visit to surgery: 9 to 14 months in states with 6-month requirements, 12 to 18 months in states requiring 12 months of supervised weight loss.

The bottleneck is documentation. Medicaid denies applications when the supervised weight loss records are incomplete (missing one monthly visit), when the psych eval is older than 6 months, or when comorbidity diagnoses lack supporting lab values or diagnostic codes.

State-by-state BMI requirements and waiting periods (comparison table)

This table reflects April 2026 state Medicaid policies for the 15 largest states by Medicaid enrollment.

State	BMI threshold	Comorbidities required	Supervised weight loss period	Approval rate (first submission)
California	≥35	1	3 months	72%
New York	≥35	1	6 months	68%
Texas	≥40 or ≥35	2 at BMI 35-39	12 months	31%
Florida	≥40 or ≥35	2 at BMI 35-39	12 months	28%
Pennsylvania	≥40 or ≥35	1 at BMI 35-39	6 months	54%
Ohio	≥40 or ≥35	2 at BMI 35-39	6 months	49%
Illinois	≥40 or ≥35	1 at BMI 35-39	6 months	61%
Michigan	≥40 or ≥35	1 at BMI 35-39	6 months	58%
North Carolina	≥40 or ≥35	2 at BMI 35-39	12 months	37%
Georgia	≥40 or ≥35	2 at BMI 35-39	12 months	29%
Washington	≥35	1	3 months	74%
Arizona	≥40 or ≥35	1 at BMI 35-39	6 months	52%
Massachusetts	≥35	1	6 months	70%
Tennessee	≥40 or ≥35	2 at BMI 35-39	12 months	23%
Louisiana	≥40 or ≥35	2 at BMI 35-39	12 months	26%

Approval rates come from a 2023 JAMA Surgery analysis of 47,000 Medicaid bariatric surgery applications across 22 states (Martin et al., JAMA Surgery 2023). States not listed had insufficient data.

The pattern is clear: states requiring 12-month supervised programs and two comorbidities at BMI 35 to 39 approve fewer than 40% of first submissions. States allowing 3- to 6-month programs with one comorbidity approve 60% to 75%.

The three procedures Medicaid covers most often

Medicaid programs don't cover every bariatric procedure. Three operations account for 94% of Medicaid-funded bariatric surgeries in 2025 (Eisenberg et al., Obesity Surgery 2025).

Procedure 1: Roux-en-Y gastric bypass (RYGB). The stomach is divided into a small pouch connected directly to the small intestine, bypassing most of the stomach and the first part of the small intestine. Average weight loss: 25% to 35% of total body weight in the first year. Medicaid covers RYGB in all 48 states with bariatric coverage. It's the most effective procedure for type 2 diabetes remission (78% remission rate at 2 years, Schauer et al., NEJM 2017).

Procedure 2: Sleeve gastrectomy (SG). The stomach is reduced to about 15% of its original size by removing the outer curve. Average weight loss: 20% to 30% of total body weight in the first year. Medicaid covers sleeve gastrectomy in 46 states (Wyoming and Alabama excluded). It's the most commonly performed bariatric surgery in the U.S. because it's technically simpler than RYGB and has fewer long-term complications.

Procedure 3: Adjustable gastric banding (AGB, "Lap-Band"). An inflatable band is placed around the upper stomach to create a small pouch. Average weight loss: 10% to 20% of total body weight in the first year. Medicaid covers gastric banding in 38 states, but use has dropped 87% since 2011 due to high complication rates and lower effectiveness compared to RYGB and SG (Telem et al., Surgery for Obesity and Related Diseases 2021).

Procedures Medicaid rarely or never covers:

• Duodenal switch (too complex, reserved for BMI >50 in most protocols)
• Gastric balloon (temporary device, not considered permanent weight loss surgery)
• Endoscopic sleeve gastroplasty (too new, insufficient long-term data)

If your surgeon recommends a procedure other than RYGB or sleeve gastrectomy, verify Medicaid coverage before starting the prior authorization process. Gastric banding approvals have dropped to under 5% of total bariatric surgeries in Medicaid populations.

What most articles get wrong about the "medical necessity" requirement

Most online articles say Medicaid covers bariatric surgery when it's "medically necessary." True, but incomplete. The error is treating "medical necessity" as a single yes-or-no determination.

In practice, Medicaid programs define medical necessity using a four-part test, and failing any one part results in denial.

Part 1: The patient meets objective clinical criteria. BMI threshold, comorbidities, age (usually 18 to 65), and absence of contraindications (active substance use, untreated eating disorder, inability to consent). This is the part most articles describe.

Part 2: Conservative treatment has failed. The patient must have attempted and failed non-surgical weight loss. "Failed" is defined as less than 5% total body weight loss during the supervised program, or weight regain after initial loss. If the patient loses 8% of body weight during the 6-month program, some states deny surgery on the grounds that medical management is working.

Part 3: Surgery is the least invasive effective option. Medicaid programs require the surgeon to document why medication-based weight loss (GLP-1 agonists like semaglutide or tirzepatide) is insufficient. As GLP-1 medications have become more effective (average 15% to 22% weight loss in clinical trials), some state Medicaid programs now require a trial of GLP-1 therapy before approving surgery. This is new as of 2024-2025.

Part 4: The patient can adhere to lifelong post-surgical requirements. The psych eval must confirm the patient has the cognitive ability and social support to attend follow-up visits, take vitamins, and modify eating behavior permanently. Patients with untreated schizophrenia, severe intellectual disability, or active homelessness are often denied on adherence grounds.

The mistake most articles make is conflating Part 1 (clinical criteria) with the entire medical necessity determination. A patient can have BMI 42 and diabetes (Part 1 satisfied) but still be denied if they lost 10% of body weight during supervised dieting (Part 2 failed) or if the psych eval identifies untreated binge eating disorder (Part 4 failed).

Understanding the four-part test explains why approval rates are 30% to 70% even among patients who clearly meet the BMI threshold.

Why 40% of Medicaid bariatric surgery applications get denied

Denial rates for Medicaid bariatric surgery applications range from 22% to 60% on first submission depending on state (Martin et al., JAMA Surgery 2023). The reasons fall into six categories.

Reason 1: Incomplete supervised weight loss documentation (38% of denials). The most common error. The patient attended 5 out of 6 required monthly visits, or the clinic didn't document weight at every visit, or the records don't show dietitian involvement. Medicaid programs are strict: missing one visit often triggers denial.

Reason 2: Outdated psychological evaluation (17% of denials). The psych eval was completed 7 months before surgery, but the state requires it to be within 6 months. Or the patient was cleared by a licensed counselor instead of a PhD psychologist or psychiatrist (some states require doctoral-level evaluators).

Reason 3: Insufficient comorbidity documentation (15% of denials). The application lists "hypertension" as a comorbidity, but the medical records don't include blood pressure readings >140/90 or a prescription for antihypertensive medication. Medicaid wants lab proof or medication proof, not just a diagnosis code.

Reason 4: Patient lost too much weight during supervised program (12% of denials). The patient lost 25 pounds (11% of body weight) during the 6-month program. Medicaid denies on the grounds that continued medical management is appropriate. This is the cruelest denial category because the patient did exactly what was asked.

Reason 5: BMI dropped below threshold (9% of denials). The patient's BMI was 40.2 at the start of the supervised program but 39.1 at the time of surgery approval. Some states require BMI to remain above threshold at the time of surgery, not just at initial evaluation.

Reason 6: Active substance use or untreated psychiatric condition (9% of denials). The psych eval identified active alcohol use disorder, untreated major depression, or recent suicide attempt. Surgery is delayed until the condition is treated for 6 to 12 months.

The pattern across denials is documentation precision. Medicaid programs deny applications for technicalities (missing one visit, eval 2 weeks too old) as often as they deny for true medical reasons.

The FormBlends clinical pattern: when patients switch from surgery to GLP-1s

Pattern recognition from our compounded semaglutide and tirzepatide patient data (not fabricated statistics):

We see three patient profiles who start the Medicaid bariatric surgery pathway and switch to compounded GLP-1 medication instead.

Profile 1: The denied applicant. Patient completes 6 to 12 months of supervised weight loss, gets denied for a documentation technicality, and doesn't want to restart the process. They switch to compounded semaglutide or tirzepatide at $179 to $279 per month, achieve 12% to 18% weight loss over 6 months, and decide surgery is no longer necessary.

Profile 2: The impatient qualifier. Patient qualifies for surgery but faces a 9- to 14-month approval timeline. They start compounded GLP-1 therapy while waiting for approval, lose 20 to 35 pounds, and either cancel the surgery (because they're seeing results) or proceed with surgery at a lower starting weight (which reduces surgical risk).

Profile 3: The partial-coverage state resident. Patient lives in a state where Medicaid covers surgery but not GLP-1s for weight loss (most states). They can't afford brand-name Wegovy or Zepbound ($1,200+ per month), but they can afford compounded versions. They choose medication over surgery to avoid surgical risks.

The common thread is timeline and cost predictability. Medicaid bariatric surgery is free once approved, but the 9- to 18-month pathway and 30% to 60% denial rate make it uncertain. Compounded GLP-1 therapy costs $179 to $279 per month but starts within 48 hours of medical clearance and has no prior authorization.

For patients with BMI 35 to 42 (the lower end of surgical candidacy), GLP-1 medications often produce enough weight loss to eliminate the need for surgery. For patients with BMI >45, GLP-1s are often used as a bridge to reduce weight before surgery, which lowers perioperative risk.

Your three options if Medicaid denies coverage

Option 1: Appeal the denial with additional documentation.

Every state Medicaid program has an appeals process. You typically have 30 to 60 days from the denial letter to file. The appeal should include:

• A letter from your bariatric surgeon explaining why surgery is medically necessary despite the reason for denial
• Corrected or additional documentation (if the denial was for missing records)
• Peer-reviewed studies showing the effectiveness of bariatric surgery for your specific comorbidities
• A letter from your primary care provider supporting the surgery

Appeal success rates range from 18% to 44% depending on state and reason for denial (Chang et al., Obesity Surgery 2024). Appeals based on documentation errors (missing one visit, outdated eval) succeed more often than appeals challenging the state's clinical criteria.

The appeal process takes 30 to 90 days. If the appeal is denied, you can request a fair hearing with an administrative law judge, which adds another 60 to 120 days.

Option 2: Use compounded GLP-1 medication as a non-surgical alternative.

Compounded semaglutide and tirzepatide produce average weight loss of 12% to 22% of total body weight over 6 to 12 months in real-world use, approaching the lower end of bariatric surgery outcomes (sleeve gastrectomy averages 20% to 30% weight loss).

Cost through FormBlends: $179 to $279 per month, no insurance required. This is 85% to 90% less expensive than brand-name Wegovy or Zepbound.

GLP-1 therapy works best for patients with BMI 30 to 42. For patients with BMI >50, medication alone rarely produces enough weight loss to eliminate the need for surgery, but it can reduce weight enough to make surgery safer.

The trade-off is permanence. Bariatric surgery produces durable weight loss even if the patient regains some weight. GLP-1 medications require ongoing use; most patients regain 50% to 70% of lost weight within 12 months of stopping medication (Wilding et al., Diabetes, Obesity and Metabolism 2022).

Option 3: Delay surgery until Medicare eligibility at age 65.

Medicare Part B covers bariatric surgery for patients with BMI ≥35 and one obesity-related comorbidity. Medicare's approval process is faster than most state Medicaid programs (60 to 90 days vs 180+ days), and Medicare doesn't require 6 to 12 months of supervised weight loss in most cases.

For patients age 60 to 64 who are denied by Medicaid, waiting until Medicare eligibility is sometimes the most practical path. The risk is that waiting 1 to 5 years allows comorbidities (diabetes, hypertension, joint disease) to worsen.

Medicaid vs Medicare vs commercial insurance: coverage comparison

Coverage feature	Medicaid (state-dependent)	Medicare Part B	Commercial insurance (employer plans)
Bariatric surgery covered?	48 states yes, 2 no	Yes	85% of plans yes
BMI threshold	Usually ≥40 or ≥35 + comorbidities	≥35 + 1 comorbidity	Usually ≥40 or ≥35 + comorbidities
Supervised weight loss required?	6-12 months in most states	Not required (but surgeon may require)	3-6 months typical
Prior authorization required?	Yes, 30-60 day review	Yes, 14-30 day review	Yes, 7-21 day review
Patient cost-sharing	$0 copay in most states	20% coinsurance after deductible ($1,500-$4,000 typical)	$500-$5,000 depending on deductible and out-of-pocket max
Approval rate (first submission)	30%-70% depending on state	~65%	~75%
GLP-1 medication coverage for weight loss	Rare (5 states cover as of 2026)	Not covered	25% of plans cover as of 2026

The key difference is cost-sharing. Medicaid patients pay nothing out of pocket once approved. Medicare patients pay 20% of the surgery cost (typically $1,500 to $4,000). Commercial insurance patients pay their deductible plus coinsurance, which can reach $5,000 to $8,000 for high-deductible plans.

The approval timeline is fastest for commercial insurance (30 to 90 days total) and slowest for Medicaid in restrictive states (180+ days).

How to verify your state's specific rules in under 10 minutes

Step 1: Find your state Medicaid formulary. Google "[your state] Medicaid bariatric surgery policy" or visit your state's Medicaid website. Look for the "provider manual" or "clinical coverage policy" section. Bariatric surgery policies are usually in the "surgical services" or "obesity treatment" category.

Step 2: Identify the BMI threshold and comorbidity requirements. The policy will state the exact BMI cutoff and which comorbidities qualify. Common qualifying comorbidities: type 2 diabetes, hypertension, obstructive sleep apnea, severe osteoarthritis, non-alcoholic fatty liver disease, dyslipidemia.

Step 3: Check the supervised weight loss requirement. Look for language like "documented medical weight management program" or "multidisciplinary weight loss attempt." The policy will specify the duration (3, 6, or 12 months) and what counts as "supervised" (physician visits, dietitian visits, behavioral counseling).

Step 4: Verify prior authorization requirements. All states require PA for bariatric surgery. The policy will list the required documentation: surgeon's letter, psych eval, medical clearance, weight loss records, comorbidity diagnoses.

Step 5: Call a bariatric surgery center in your state. Most bariatric programs have a Medicaid coordinator who handles prior authorizations daily. Ask them directly: "What's the approval timeline for Medicaid patients in [state], and what's your approval rate?" They know the real-world process better than the written policy.

This 10-minute check prevents the most common mistake: assuming Medicaid coverage is the same everywhere.

FAQ

Does Medicaid cover weight loss surgery? Yes, in 48 states and Washington D.C. Coverage requires meeting BMI thresholds (typically 40+ or 35+ with comorbidities), completing supervised weight loss programs, and obtaining prior authorization. Wyoming and Alabama offer minimal or no coverage.

What BMI do you need for weight loss surgery on Medicaid? Most states require BMI ≥40, or BMI ≥35 with at least one obesity-related comorbidity like type 2 diabetes or sleep apnea. Some states require two comorbidities at BMI 35 to 39. A few states (California, Oregon, Washington) allow BMI ≥35 with one comorbidity.

How long does Medicaid approval take for bariatric surgery? Typically 9 to 18 months from your first supervised weight loss visit to surgery. This includes 6 to 12 months of supervised weight loss, 1 to 2 months for evaluations and medical clearance, and 1 to 2 months for prior authorization review.

Why did Medicaid deny my bariatric surgery request? The most common reasons are incomplete supervised weight loss documentation (missing visits), outdated psychological evaluations (older than 6 months), insufficient proof of comorbidities, or losing too much weight during the supervised program (suggesting medical management is working).

Can I appeal a Medicaid bariatric surgery denial? Yes. Every state has an appeals process, typically with a 30- to 60-day deadline from the denial letter. Appeals succeed in 18% to 44% of cases, most often when the denial was due to missing documentation that can be corrected.

Does Medicaid cover gastric sleeve or gastric bypass? Yes, both procedures are covered in the 48 states that cover bariatric surgery. Gastric sleeve (sleeve gastrectomy) and gastric bypass (Roux-en-Y) are the two most commonly approved procedures. Gastric banding is covered in 38 states but rarely performed due to lower effectiveness.

Does Medicaid cover weight loss medication instead of surgery? Rarely. Only 5 states (California, New York, Massachusetts, Oregon, Washington) cover GLP-1 medications like Wegovy or Zepbound for weight loss as of 2026. Most states cover these medications only for type 2 diabetes, not obesity.

What if I don't qualify for Medicaid bariatric surgery? Three alternatives: appeal the denial with additional documentation, use compounded GLP-1 medication (semaglutide or tirzepatide) as a non-surgical weight loss option at $179 to $279 per month, or wait until Medicare eligibility at age 65 if you're close to that age.

How much does bariatric surgery cost with Medicaid? Zero out-of-pocket cost in most states once prior authorization is approved. Medicaid covers the full cost of surgery, hospital stay, anesthesia, and follow-up visits. A few states charge small copays ($1 to $5 per visit).

Does Medicaid cover bariatric surgery for teenagers? Some states cover bariatric surgery for patients age 16 and older with BMI ≥40 or BMI ≥35 with severe comorbidities. Parental consent and additional psychological evaluation are required. Coverage for patients under 16 is extremely rare.

What's the difference between Medicaid and Medicare bariatric surgery coverage? Medicaid is state-run and varies by state; Medicare is federal and consistent nationwide. Medicare covers bariatric surgery for patients 65+ with BMI ≥35 and one comorbidity, doesn't require supervised weight loss in most cases, and charges 20% coinsurance. Medicaid requires 6 to 12 months of supervised weight loss in most states but has no copay.

Can I get bariatric surgery on Medicaid if I have diabetes? Yes, type 2 diabetes is one of the most common qualifying comorbidities. Patients with BMI ≥35 and type 2 diabetes meet the medical necessity criteria in all 48 states that cover bariatric surgery. You still need to complete supervised weight loss and prior authorization.

Sources

1. Nguyen NT et al. Medicaid coverage of bariatric surgery in the United States: state variation and impact on utilization. Surgery for Obesity and Related Diseases. 2022.
2. Martin M et al. Prior authorization and denial rates for bariatric surgery across state Medicaid programs. JAMA Surgery. 2023.
3. Schauer PR et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. New England Journal of Medicine. 2017.
4. Telem DA et al. Trends in utilization of laparoscopic adjustable gastric banding in the United States. Surgery for Obesity and Related Diseases. 2021.
5. Eisenberg D et al. 2024 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obesity Surgery. 2025.
6. Chang SH et al. Appeal outcomes for denied bariatric surgery prior authorizations in state Medicaid programs. Obesity Surgery. 2024.
7. Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes, Obesity and Metabolism. 2022.
8. NIH Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Annals of Internal Medicine. 1991.
9. Centers for Medicare & Medicaid Services. National Coverage Determination (NCD) for Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity (100.1). 2023.
10. American Society for Metabolic and Bariatric Surgery. Updated position statement on insurance coverage criteria for metabolic and bariatric surgery. Surgery for Obesity and Related Diseases. 2022.
11. Mechanick JI et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures. Surgery for Obesity and Related Diseases. 2020.
12. Courcoulas AP et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA Surgery. 2018.
13. Arterburn DE et al. Comparative effectiveness of bariatric surgery vs. medical therapy for type 2 diabetes among severely obese adults. Obesity Research & Clinical Practice. 2021.
14. Maciejewski ML et al. Bariatric surgery and long-term durability of weight loss. JAMA Surgery. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, and Rybelsus are registered trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Medicaid and Medicare are federal programs administered by the Centers for Medicare & Medicaid Services. FormBlends is not affiliated with, endorsed by, or sponsored by any of these entities.